HK Stock MarketDetailed Quotes

01336 NCI

Watchlist

15.940
+0.100+0.63%

Market Closed Sep 13 16:08 CST

49.73BMarket Cap4.62P/E (TTM)

NCI Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

(Q3)Mar 31, 2022

Assets

Fixed time deposit

9.60%268.04B

11.03%255.24B

12.50%255.98B

33.23%264.66B

30.96%244.56B

35.51%229.89B

35.01%227.55B

32.66%198.65B

43.06%186.75B

45.32%169.65B

Reserve deposits

----

--378.39B

----

Cash and equivalents

39.84%25.99B

20.93%25.37B

23.89%21.79B

31.68%17B

4.34%18.59B

19.98%20.98B

13.76%17.59B

-4.19%12.91B

5.43%17.81B

-2.84%17.49B

Reinsurance assets

1.27%10.1B

0.73%9.88B

-7.44%9.8B

--10.01B

151.72%9.97B

--9.81B

166.01%10.59B

----

8.67%3.96B

----

Refundable deposit

-5.63%1.81B

-6.16%1.8B

4.02%1.78B

3.21%1.77B

11.95%1.92B

11.78%1.92B

0.00%1.72B

Investment income receivable

----

-99.50%76M

----

-96.99%413M

----

25.46%15.14B

----

18.89%13.71B

----

Insurance receivables

----

-3.57%5.86B

7.04%5.75B

-2.75%4.99B

Reinsurance receivables

----

220.89%507M

----

455.32%261M

Financial assets at fair value through profit or loss

30.79%475.81B

11.41%423.43B

378.50%380.24B

427.28%369.84B

375.81%363.8B

435.63%380.08B

13.16%79.47B

6.59%70.14B

118.97%76.46B

121.15%70.96B

Available for sale financial assets

----

1.01%388.31B

----

-2.86%396.79B

Buying back the sale of financial assets

29.14%8.49B

-83.36%1.06B

-40.49%5.27B

-50.65%5.52B

145.50%6.57B

-43.04%6.35B

115.15%8.85B

141.36%11.18B

-52.69%2.68B

53.51%11.14B

Investment in joint ventures and joint ventures

182.91%16.29B

----

-11.10%5.17B

----

4.88%5.76B

----

6.75%5.82B

----

6.52%5.49B

----

Held to maturity investments

----

19.01%346.85B

15.66%327.03B

13.90%309.95B

Investment property

----

-2.56%9.26B

----

2.04%9.39B

----

1.43%9.5B

----

9.21%9.2B

----

9.12%9.36B

Property plant and equipment

2.29%18.18B

----

1.51%18.02B

----

-1.12%17.77B

----

-1.23%17.75B

----

8.31%17.97B

----

Deferred tax assets

----

1,163.36%15.93B

----

83.55%7.6B

----

-49.44%1.26B

----

2,045.08%4.14B

----

1,293.30%2.49B

Protecting a pledge loan

----

8.05%43B

7.66%42.23B

7.71%41.54B

Special items of assets

7.35%337.59B

13.43%33.25B

-22.05%351.61B

-71.41%28.28B

-35.28%314.49B

-71.90%29.31B

-6.45%451.1B

6.78%98.93B

4.06%485.91B

20.27%104.32B

Total assets

14.17%1.49T

11.39%1.43T

15.50%1.4T

14.15%1.36T

10.15%1.31T

12.15%1.28T

7.73%1.21T

12.58%1.2T

16.27%1.19T

14.57%1.14T

Liabilities

Deposit of the Insured

----

17.44%66.96B

----

14.16%61.59B

Insurance contract

14.77%1.27T

15.28%1.22T

13.16%1.15T

--1.13T

18.38%1.1T

--1.06T

17.31%1.01T

----

13.90%932.57B

----

Investment contract

----

18.27%65.27B

----

Reinsurance premium payable

----

235.90%655M

379.39%628M

119.22%730M

Insurance accounts payable

----

-5.53%5.81B

-12.23%5.8B

-9.16%6.17B

Dividend for insured

----

128.57%16M

-97.69%15M

51.65%734M

Advance payment

----

-23.84%262M

----

37.20%343M

----

52.21%344M

----

8.23%250M

6.67%288M

-23.65%226M

Reserve for Outstanding Losses

----

22.00%2.52B

----

20.60%2.14B

Selling repo securities

----

31.36%75.7B

----

174.73%86.11B

----

104.14%57.63B

----

63.92%31.34B

----

484.11%28.23B

Financial liabilities measured at fair value through profit or loss

142.89%9.88B

-59.17%3.24B

-86.12%3.59B

14.96%10.37B

-47.78%4.07B

-34.78%7.93B

890.70%25.88B

334.81%9.02B

182.82%7.79B

14.77%12.15B

Deferred tax liabilities

----

-27.03%81M

----

20.69%70M

----

552.94%111M

----

-92.76%58M

----

-98.48%17M

Current income tax liabilities

-51.43%17M

-48.16%127M

23.81%26M

37.25%210M

-22.22%35M

99.19%245M

-66.67%21M

-57.73%153M

-78.67%45M

-83.24%123M

Special items of liabilities

43.78%127.66B

-2.32%35.53B

90.17%148.05B

-96.69%32.37B

23.99%88.79B

-96.09%36.37B

-6.59%77.85B

12.62%977.46B

129.76%71.61B

14.29%929.35B

Total liabilities

17.36%1.4T

14.96%1.34T

16.23%1.3T

14.69%1.26T

10.41%1.2T

11.45%1.16T

9.59%1.12T

14.44%1.1T

18.38%1.08T

16.46%1.04T

Total assets less total liabilities

-19.82%90.05B

-22.69%94.03B

7.24%105.09B

8.26%108.34B

7.45%112.31B

19.31%121.62B

-9.69%98B

-4.49%100.07B

-1.83%104.52B

-1.77%101.94B

Equity

Share capital

0.00%3.12B

Reserve

-190.64%-12.85B

----

-45.26%9.82B

----

-71.52%14.18B

----

-66.17%17.95B

----

-5.19%49.79B

----

Capital reserves

----

-0.06%23.98B

----

-0.10%23.98B

----

0.38%23.99B

----

0.41%24B

----

-0.04%23.9B

Hold profit

5.02%99.76B

----

19.78%92.12B

----

84.13%94.99B

----

46.97%76.91B

----

1.51%51.59B

----

Undistributed profit

----

0.68%97.07B

----

83.28%94.55B

----

79.62%96.41B

----

-1.22%51.59B

----

2.73%53.68B

Special items of shareholders' equity

----

5.55%15.22B

----

62.70%14.42B

----

62.70%14.42B

----

19.52%8.86B

----

19.52%8.86B

Shareholders' equity

-19.83%90.03B

-22.70%94B

7.24%105.07B

8.25%108.31B

7.45%112.29B

19.31%121.6B

-9.70%97.98B

-4.49%100.05B

-1.84%104.5B

-1.77%101.92B

Minority interests

17.39%27M

18.18%26M

19.05%25M

21.05%23M

22.22%22M

23.53%21M

18.75%19M

26.67%19M

28.57%18M

Total equity

-19.82%90.05B

-22.69%94.03B

7.24%105.09B

8.26%108.34B

7.45%112.31B

19.31%121.62B

-9.69%98B

-4.49%100.07B

-1.83%104.52B

-1.77%101.94B

Total equity and total liabilities

14.17%1.49T

11.39%1.43T

15.50%1.4T

14.15%1.36T

10.15%1.31T

12.15%1.28T

7.73%1.21T

12.58%1.2T

16.27%1.19T

14.57%1.14T

Currency Unit

CNY

Accounting Standards

IAS

CAS (2007)

IAS

CAS (2007)

IAS

CAS (2007)

IAS

CAS (2007)

IAS

CAS (2007)

Audit Opinions

Unqualified Opinion

Auditor

Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership)

	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022	(Q3)Mar 31, 2022
Assets
Fixed time deposit	9.60%268.04B	11.03%255.24B	12.50%255.98B	33.23%264.66B	30.96%244.56B	35.51%229.89B	35.01%227.55B	32.66%198.65B	43.06%186.75B	45.32%169.65B
Reserve deposits	----	----	----	----	----	----	--378.39B	----	----	----
Cash and equivalents	39.84%25.99B	20.93%25.37B	23.89%21.79B	31.68%17B	4.34%18.59B	19.98%20.98B	13.76%17.59B	-4.19%12.91B	5.43%17.81B	-2.84%17.49B
Reinsurance assets	1.27%10.1B	0.73%9.88B	-7.44%9.8B	--10.01B	151.72%9.97B	--9.81B	166.01%10.59B	----	8.67%3.96B	----
Refundable deposit	-5.63%1.81B	-6.16%1.8B	4.02%1.78B	3.21%1.77B	11.95%1.92B	11.78%1.92B	0.00%1.72B	0.00%1.72B	0.00%1.72B	0.00%1.72B
Investment income receivable	----	----	-99.50%76M	----	-96.99%413M	----	25.46%15.14B	----	18.89%13.71B	----
Insurance receivables	----	----	----	----	----	----	----	-3.57%5.86B	7.04%5.75B	-2.75%4.99B
Reinsurance receivables	----	----	----	----	----	----	----	220.89%507M	----	455.32%261M
Financial assets at fair value through profit or loss	30.79%475.81B	11.41%423.43B	378.50%380.24B	427.28%369.84B	375.81%363.8B	435.63%380.08B	13.16%79.47B	6.59%70.14B	118.97%76.46B	121.15%70.96B
Available for sale financial assets	----	----	----	----	----	----	----	1.01%388.31B	----	-2.86%396.79B
Buying back the sale of financial assets	29.14%8.49B	-83.36%1.06B	-40.49%5.27B	-50.65%5.52B	145.50%6.57B	-43.04%6.35B	115.15%8.85B	141.36%11.18B	-52.69%2.68B	53.51%11.14B
Investment in joint ventures and joint ventures	182.91%16.29B	----	-11.10%5.17B	----	4.88%5.76B	----	6.75%5.82B	----	6.52%5.49B	----
Held to maturity investments	----	----	----	----	----	----	----	19.01%346.85B	15.66%327.03B	13.90%309.95B
Investment property	----	-2.56%9.26B	----	2.04%9.39B	----	1.43%9.5B	----	9.21%9.2B	----	9.12%9.36B
Property plant and equipment	2.29%18.18B	----	1.51%18.02B	----	-1.12%17.77B	----	-1.23%17.75B	----	8.31%17.97B	----
Deferred tax assets	----	1,163.36%15.93B	----	83.55%7.6B	----	-49.44%1.26B	----	2,045.08%4.14B	----	1,293.30%2.49B
Protecting a pledge loan	----	----	----	----	----	----	----	8.05%43B	7.66%42.23B	7.71%41.54B
Special items of assets	7.35%337.59B	13.43%33.25B	-22.05%351.61B	-71.41%28.28B	-35.28%314.49B	-71.90%29.31B	-6.45%451.1B	6.78%98.93B	4.06%485.91B	20.27%104.32B
Total assets	14.17%1.49T	11.39%1.43T	15.50%1.4T	14.15%1.36T	10.15%1.31T	12.15%1.28T	7.73%1.21T	12.58%1.2T	16.27%1.19T	14.57%1.14T
Liabilities
Deposit of the Insured	----	----	----	----	----	----	----	17.44%66.96B	----	14.16%61.59B
Insurance contract	14.77%1.27T	15.28%1.22T	13.16%1.15T	--1.13T	18.38%1.1T	--1.06T	17.31%1.01T	----	13.90%932.57B	----
Investment contract	----	----	----	----	----	----	----	----	18.27%65.27B	----
Reinsurance premium payable	----	----	----	----	----	----	----	235.90%655M	379.39%628M	119.22%730M
Insurance accounts payable	----	----	----	----	----	----	----	-5.53%5.81B	-12.23%5.8B	-9.16%6.17B
Dividend for insured	----	----	----	----	----	----	----	128.57%16M	-97.69%15M	51.65%734M
Advance payment	----	-23.84%262M	----	37.20%343M	----	52.21%344M	----	8.23%250M	6.67%288M	-23.65%226M
Reserve for Outstanding Losses	----	----	----	----	----	----	----	22.00%2.52B	----	20.60%2.14B
Selling repo securities	----	31.36%75.7B	----	174.73%86.11B	----	104.14%57.63B	----	63.92%31.34B	----	484.11%28.23B
Financial liabilities measured at fair value through profit or loss	142.89%9.88B	-59.17%3.24B	-86.12%3.59B	14.96%10.37B	-47.78%4.07B	-34.78%7.93B	890.70%25.88B	334.81%9.02B	182.82%7.79B	14.77%12.15B
Deferred tax liabilities	----	-27.03%81M	----	20.69%70M	----	552.94%111M	----	-92.76%58M	----	-98.48%17M
Current income tax liabilities	-51.43%17M	-48.16%127M	23.81%26M	37.25%210M	-22.22%35M	99.19%245M	-66.67%21M	-57.73%153M	-78.67%45M	-83.24%123M
Special items of liabilities	43.78%127.66B	-2.32%35.53B	90.17%148.05B	-96.69%32.37B	23.99%88.79B	-96.09%36.37B	-6.59%77.85B	12.62%977.46B	129.76%71.61B	14.29%929.35B
Total liabilities	17.36%1.4T	14.96%1.34T	16.23%1.3T	14.69%1.26T	10.41%1.2T	11.45%1.16T	9.59%1.12T	14.44%1.1T	18.38%1.08T	16.46%1.04T
Total assets less total liabilities	-19.82%90.05B	-22.69%94.03B	7.24%105.09B	8.26%108.34B	7.45%112.31B	19.31%121.62B	-9.69%98B	-4.49%100.07B	-1.83%104.52B	-1.77%101.94B
Equity
Share capital	0.00%3.12B	0.00%3.12B	0.00%3.12B	0.00%3.12B	0.00%3.12B	0.00%3.12B	0.00%3.12B	0.00%3.12B	0.00%3.12B	0.00%3.12B
Reserve	-190.64%-12.85B	----	-45.26%9.82B	----	-71.52%14.18B	----	-66.17%17.95B	----	-5.19%49.79B	----
Capital reserves	----	-0.06%23.98B	----	-0.10%23.98B	----	0.38%23.99B	----	0.41%24B	----	-0.04%23.9B
Hold profit	5.02%99.76B	----	19.78%92.12B	----	84.13%94.99B	----	46.97%76.91B	----	1.51%51.59B	----
Undistributed profit	----	0.68%97.07B	----	83.28%94.55B	----	79.62%96.41B	----	-1.22%51.59B	----	2.73%53.68B
Special items of shareholders' equity	----	5.55%15.22B	----	62.70%14.42B	----	62.70%14.42B	----	19.52%8.86B	----	19.52%8.86B
Shareholders' equity	-19.83%90.03B	-22.70%94B	7.24%105.07B	8.25%108.31B	7.45%112.29B	19.31%121.6B	-9.70%97.98B	-4.49%100.05B	-1.84%104.5B	-1.77%101.92B
Minority interests	17.39%27M	18.18%26M	19.05%25M	21.05%23M	21.05%23M	22.22%22M	23.53%21M	18.75%19M	26.67%19M	28.57%18M
Total equity	-19.82%90.05B	-22.69%94.03B	7.24%105.09B	8.26%108.34B	7.45%112.31B	19.31%121.62B	-9.69%98B	-4.49%100.07B	-1.83%104.52B	-1.77%101.94B
Total equity and total liabilities	14.17%1.49T	11.39%1.43T	15.50%1.4T	14.15%1.36T	10.15%1.31T	12.15%1.28T	7.73%1.21T	12.58%1.2T	16.27%1.19T	14.57%1.14T
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	CAS (2007)	IAS	CAS (2007)	IAS	CAS (2007)	IAS	CAS (2007)	IAS	CAS (2007)
Audit Opinions	--	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--	--	--
Auditor	--	--	Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership)	--	--	--	Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership)	--	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

01336 NCI

NCI Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target